Prof. Hülya AYAR KAYALI

Since 2014, Prof. Hülya Ayar Kayalı has been a professor at the Department of Chemistry, Faculty of Science, Dokuz Eylül University. Her research focuses on biopharmaceutical technologies, molecular biology, biochemistry, and cancer therapeutics, with particular emphasis on targeted drug delivery systems, protein engineering, and biosensor applications.

As the head of the Biopharmaceutical Technologies and Bioanalysis Laboratory, Prof. Ayar Kayalı leads pioneering research in intelligent chemotherapeutic agents and drug delivery systems, development of diagnostic kits, and molecular characterization of targeted therapeutics. Her team employs cutting-edge methodologies, including recombinant protein production, bioinformatics, proteomics, and advanced molecular imaging techniques, to investigate key cellular pathways involved in cancer progression and resistance. One of her major research areas is the development of antibody-drug conjugates (ADCs) and exosome-based drug delivery systems for overcoming multi-drug resistance (MDR) in cancer therapy.

https://www.ibg.edu.tr/research-programs/groups/ayar-kayali-lab/